New England Investors Hot for Healthcare

Last year, VCs swarmed New England, raising the dollar volume of their healthcare-related investments by 44 percent over 2005, according to a report produced jointly by PricewaterhouseCoopers and the National Venture Capital Association. Deal volume likewise rose 21 percent in the region. In all, New...

North Carolina Entrepreneur Bypasses Angels and VCs

North Carolina serial entrepreneur Max Wallace has devised what he says is a new business model for his latest medical start up. The company, called TheraLogics, is looking at ways to limit the role of inflammation in disease. To fund it, Wallace is bypassing traditional money sources such as angels and VCs....

Coming Soon: Ad-Supported EMRs

Practice Fusion has given physicians a powerful incentive to upgrade their antiquated paper-based, patient-record systems. The San Francisco start-up will digitize the records for free. The only catch, according to the San Francisco Chronicle, is that doctors reviewing a patient’s chart will also see...

Approval Triggers Cash Infusion

The FDA approval of Antares’ Elestrin resulted in a $1.75 million milestone payment from Bradley Pharmaceuticals. The payment was received pursuant to a marketing agreement Bradley signed with Biosante Pharmaceuticals (a licensee of Antares). Elestrin, used to treat hot flashes in menopausal women,...

Cambridge Heart Gets Boost from St. Jude

Cambridge Heart inked a three-year agreement with St. Jude Medical last week, turning over to the behemoth sales and marketing responsibilities for its HearTwave II Microvolt T-Wave Alternans System and sensors to North American cardiologists and electrophysiologists. In exchange for the marketing rights,...

CardioNet Equity Bridge Financing Breaks Record

San Diego-based CardioNet, which makes wireless mobile cardiac outpatient monitoring solutions, announced today that it closed $110 million in private financing. The company’s chairman and CEO, James Sweeney, says the $110 million is one of the largest private placements of equity bridge financing in...

Entrada Eases Transition to Mexico

Beginning in May, NxStage, a manufacturer of portable kidney dialysis machines, will move certain aspects of its System One production to Fresnillo, Mexico, in an attempt to control costs. Overseeing the move will be Entrada Group, a Texas-based firm that provides manufacturing facilities and contract...

Beckman Coulter Pays Top Dollar for Biosite

Beckman Coulter, a biomedical testing company, announced yesterday that it would acquire San Diego-based Biosite for $1.55 billion. The purchase will increase Beckman Coulter’s presence in the diagnostic-test market, but industry watchers are saying the Fullerton, CA buyer may have overpaid. According...